We are live on !
Find out more
Sozo Ventures GP II Portfolio holdings
AUM
$1.33B
Turnover
0%
1-Year Est. Return
9.22%
This Fund
S&P 500
This Quarter Est. Return
+60.14%
1 Year Est. Return
+9.22%
3 Year Est. Return
+8.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.33B
AUM Growth
+$471M
(+55%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.5
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Metagenomi Therapeutics
MGX
$31.4M
| $1.33B | 100% |
581,577
| – | – |
2024 Q1
6 quarters
|
|
Similar funds
Sozo Ventures GP II's Q3 2025 Portfolio in Review
As of Q3 2025, Sozo Ventures GP II held 1 position worth $1.33B, up 55% from $861M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 0%. Sozo Ventures GP II opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Sozo Ventures GP II's ten largest holdings make up 100% of its $1.33B portfolio in Q3 2025.
- Sozo Ventures GP II opened 0 new positions and closed 0 in Q3 2025.
- Sozo Ventures GP II's portfolio value rose 55% quarter-over-quarter to $1.33B.
Based on Sozo Ventures GP II's 13F filing for Q3 2025, filed 6 Nov 2025.